Vietnam is aiming to attract overseas investment to encourage domestic drug development through the amended 2016 Law on ...

Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft ...

Clinical operations teams can expect a high return on investments in AI in the next 5–10 years, according to speakers at ...

IPA has entered a strategic partnership with Ribopro aiming to transform therapeutic antibody discovery and development.

Last month, the NICE endorsed Casgevy for use in the NHS under a managed access scheme to treat sickle cell disease.

The FDA has granted fast track designation to Pyxis oncology’s PYX-201 for the treatment of adults with R/M HNSCC.

Eli Lilly has announced plans to expand its domestic medicine production in the US with four new pharmaceutical manufacturing ...